Browsing by Author "Meriaux, S."
Now showing 1 - 1 of 1
Results Per Page
Sort Options
- Focused Neuroprotection in Parkinson's Disease: Effects of N-Acetylcysteine and MRI-guided Ultrasound NeuromodulationPublication . Silva, Rita Caridade; Araújo, B.; Vilaça-Ferreira, A. C.; Vilela, C.; Teixeira, C.; Martins-Macedo, J.; Soares-Guedes, C.; Gomes, Eduardo D.; Meriaux, S.; Larrat, B.; Wade-Martins, R.; Fernandes, H. J.; Teixeira, F.; Gomes, EduardoParkinson’s Disease (PD) is characterized by a progressive degeneration of dopaminergic neurons (DAn) in the brain, leading to severe symptomatology. Current treatments mainly address motor symptoms rather than preventing DAn damage or degeneration. Hence, there is an urgent need for novel strategies, particularly those that can combine neuroprotective and neuroregenerative approaches [1]. Drug repurposing is a powerful method for identifying new applications for approved drugs outside the scope of the original medical indication [2]. Under this concept, N-acetylcysteine (NAC), a potent antioxidant, has shown therapeutic abilities in modulating oxidative stress and preventing dopamine-induced cell death [3], suggesting potential disease-modifying actions in PD. Notably, recent data from our team revealed that NAC could restore dopamine transporter (DAT) levels in the dorsal striatum of PD animals [4].